Pages
Products
Inactivated Influenza A H1N1pdm (Canada/6294/09)

Inactivated Influenza A H1N1pdm (Canada/6294/09)

Cat.No. :  VNV-108

Storage:  -80°C Shipping:  Dry ice

Inquire for Price

Product Infomation

Cat. No. VNV-108
Description Wild type influenza A H1N1pdm (Canada/6294/09) particles which are inactivated by heat treatment. This product is intended for research use only.
Shipping Dry ice
Storage -80°C
Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Influenza A virus (H1N1pdm) (Canada/6294/09) is a pandemic H1N1 strain that emerged in 2009 and caused widespread illness worldwide. The virus is primarily transmitted through respiratory droplets expelled by infected individuals when they cough, sneeze, or talk. It can also be transmitted through direct contact with contaminated surfaces, where the virus can remain viable for several hours. The virus targets respiratory epithelial cells, binding to sialic acid receptors (α-2,6-linked) primarily found in the upper respiratory tract. Once inside the host, the virus replicates and disrupts host cell function, triggering an inflammatory response characterized by fever, cough, sore throat, and fatigue. Severe cases may develop into viral pneumonia or acute respiratory distress syndrome (ARDS), particularly in high-risk groups such as pregnant women, young children, and immunocompromised individuals. The H1N1pdm strain is more pathogenic than seasonal influenza viruses because it is able to evade pre-existing immunity due to antigenic drift and reassortment events that occurred within the swine host prior to zoonotic transmission to humans.

Influenza A virus H1N1pdm (Canada/6294/09) has a typical influenza A virus structure, with a lipid envelope studded with two key glycoproteins: hemagglutinin (HA) and neuraminidase (NA). The HA protein facilitates viral entry into host cells by mediating host cell receptor binding and membrane fusion, while the NA protein releases progeny virions by cleaving sialic acid. The viral envelope also contains the ion channel protein M2 and a layer of matrix protein (M1) beneath the lipid bilayer. Its genome consists of eight single-stranded negative-sense RNA segments encoding 11 proteins: PB2, PB1, PA, HA, NP, NA, M1, M2, NS1, NEP, and PB1-F2. The Canada/6294/09 isolate possesses a unique genetic structure derived from a triple reassortment of avian, swine, and human influenza viruses, with segments derived from Eurasian swine influenza viruses (HA, NA), North American swine influenza viruses (PB2, PB1, PA, NP, M, NS), and the H3N2 lineage of human influenza viruses. Notably, the HA gene carries the D222G mutation, which is associated with enhanced binding to lower respiratory tract receptors and increased virulence.

Neutrophils are the most abundant cells in the human immune system. Here, the researchers explored the role of neutrophils in host defense during influenza A virus infection, specifically evaluating whether they are involved in the pathogenesis of H5N1 influenza virus. The results showed that influenza virus-infected alveolar epithelial cells allowed neutrophil migration. Compared with seasonal influenza H1N1 virus-infected alveolar epithelial cells, the number of migrating neutrophils was significantly increased in H5N1 influenza virus-infected alveolar epithelial cells. Neutrophils were equally sensitive to H5N1 and H1N1 virus infection and had similar levels of viral gene transcription. Efficient replication was observed in H5N1 virus-infected neutrophils. H5N1 virus-induced cytokine and chemokine gene transcription levels were higher than those in H1N1 virus-infected neutrophils, including TNF-α, IFN-β, CXCL10, MIP-1α, and IL-8. This infers that the inflammatory response caused by H5N1 virus is more intense than that of H1N1 virus. Notably, NADPH oxidase-dependent NET formation was observed in neutrophils only at 6 h after infection with H1N1 virus, whereas NET formation was not observed after infection with H5N1 virus. These findings demonstrate that NET formation is abrogated after H5N1 influenza virus infection and may exacerbate the severity of H5N1 disease.

Here, the researchers performed an infection experiment to examine whether influenza viruses are able to infect and replicate in neutrophils. Influenza M genes were readily detected at 1 hpi, with a copy number of 106 for both influenza virus subtypes, H5N1 and H1N1. There was no trend toward an increase in viral gene copy number in cells at subsequent time points, 3, 6, to 16 hpi (Figure 1a). De novo viral proteins were investigated by immunofluorescence assay at 16 hpi, revealing evidence of viral antigens in the multilobed nuclei of neutrophils infected with the four viruses, while mock-infected cells remained unstained. This finding suggests that viral protein translation has occurred in H5N1- and H1N1-infected neutrophils (Figure 1b). To examine whether infectious virions were formed, culture supernatants collected at different time points post-infection were titrated (Figure 1c). For better comparison, the researchers set up heat-killed controls of H5N1, seasonal, and pandemic H1N1 (H1N1pdm). After 16 hpi, the infectious virus titers in the culture supernatants of cells infected with H5N1 virus were significantly higher than those of the heat-inactivated control, while the infectious virus titers in the culture supernatants of cells infected with seasonal and pandemic H1N1 virus were significantly lower than those of the heat-inactivated control. This suggests that H5N1 virus replicates efficiently in neutrophils infected with H5N1 virus, while H1N1 virus is actively inactivated by neutrophils (Figure 1c).

Influenza virus infection and replication competence in naïve neutrophils.Figure 1. Influenza virus infection and replication competence in naïve neutrophils. (Chan L L Y, et al., 2020)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction